Dec. 11, 2019 Price forecast | 2 weeks: -8.02% | 1 month: -14.10% | 3 months: -18.46%


TLRY stock forecast

Our latest prediction for Tilray, Inc.'s stock price was made on the Dec. 11, 2019 when the stock price was at 18.20$.

In the short term (2weeks), TLRY's stock price should underperform the market by -8.02%. During that period the price should oscillate between -11.64% and +9.12%.

In the medium term (3months), TLRY's stock price should underperform the market by -18.46%. During that period the price should oscillate between -38.47% and +18.60%.


About Tilray, Inc.

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

At the moment the company generates 136M USD in revenues.

On its last earning announcement, the company reported a loss of -1.47$ per share.

The book value per share is 0.38$

Tilray, Inc. website


Three months stock forecastDec. 11, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
136M 27.00% -111M -82.10% -132M -1.47 - - 86M 0.38 -187M -67M -254M